Intronic branchpoint-to-acceptor variants underlying inborn errors of immunity

Clinical laboratories searching for pathogenic variants focus mostly on the protein-coding region and corresponding essential splicing sites. Screening for variants in intronic regions requires dedicated bioinformatics tools and detailed experimental studies to confirm deleteriousness and pathogenicity. We report intronic variants in a cohort of eight patients from seven kindreds with unexplained inborn errors of immunity (IEI). Using ad hoc bioinformatics tools, we identified seven kindreds carrying three branchpoint variants at three loci (<i>BTK</i>, <i>SH2D1A</i>, and <i>WAS</i>) and four AG-gain acceptor site variants at another three loci (<i>DOCK8</i>, <i>NFKB1</i>, <i>STXBP2</i>, and <i>UNC13D</i>). The variants were located between positions -9 and -49 relative to the wild-type acceptor site. The deleteriousness and, thus, pathogenicity of these variants were confirmed by exon-captured transcriptome studies and flow cytometry analyses of protein production or function. Our findings indicate that intronic variants should be systematically screened and investigated, even in clinical laboratory settings.